Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
Por um escritor misterioso
Descrição
Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
pediatric acute lymphoblastic leukemia - List of Frontiers' open access articles
Frontiers Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers
The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment - ScienceDirect
Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations
Frontiers in Pharmacology on X: New Research: Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs #pharmacology / X
45623 PDFs Review articles in PHARMACOGENETICS
Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy
Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations
Frontiers in Pharmacology Pharmacogenetics and Pharmacogenomics
Recent Advances in Managing Acute Lymphoblastic Leukemia
Cancers, Free Full-Text
Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients
